{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:35:20Z","timestamp":1790714120071,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiographic parameters of systolic and diastolic dysfunction in such patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this cross-sectional study, we evaluated patients with RA who were referred to our clinic from October 2017 to August 2018. After the exclusion of patients with concomitant CVD, all patients underwent transthoracic echocardiography and measurement of plasma autoantibodies. Moreover, possible confounders\u2014including medications, CVD risk factors, Framingham risk score, disease activity score-28, duration of disease, simple disease activity index, and functional status\u2014were assessed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We studied 135 patients with RA (mean age\u2009=\u200952.3\u2009years; 111 (82.2%) females). We had missing data rates of up to 8.9% for some characteristics. E velocity was inversely correlated with rheumatoid factor (<jats:italic>P<\/jats:italic>\u2009=\u20090.009). Furthermore, the plasma levels of anti-citrullinated protein and anti-modified citrullinated vimentin (anti-MCV) antibodies were negatively correlated with left ventricular ejection fraction (LVEF) (<jats:italic>P<\/jats:italic>\u2009=\u20090.019 and <jats:italic>P<\/jats:italic>&lt;0.001, respectively). After an adjustment for possible confounders, the linear regression model demonstrated that the anti-MCV level and the patient\u2019s age are significant predictors of LVEF. The receiver operating characteristic curve showed that anti-MCV antibody titer\u2265547.5 (IU\/mL) signifies reduced LVEF (&lt;50%) with a sensitivity of 85.7% and specificity of 93% (C-statistic\u2009=\u20090.843).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our findings showed a significant inverse correlation between anti-MCV antibody titer and LVEF. These results indicate that the application of anti-MCV is promising for the screening and early detection of cardiac systolic dysfunction. Future prospective studies will determine its role.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01676-x","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:12:03Z","timestamp":1598415123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Somayye","family":"Norouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Javinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2635-2656","authenticated-orcid":false,"given":"Maryam","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"6","key":"1676_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jbspin.2016.07.007","volume":"83","author":"E Minichiello","year":"2016","unstructured":"Minichiello E, Semerano L, Boissier MC. Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint Bone Spine. 2016;83(6):625\u201330.","journal-title":"Joint Bone Spine"},{"issue":"7","key":"1676_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1676_CR3","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/acr.23548","volume":"70","author":"J Widdifield","year":"2018","unstructured":"Widdifield J, Paterson JM, Huang A, Bernatsky S. Causes of death in rheumatoid arthritis: how do they compare to the general population? Arthritis Care Res. 2018;70(12):1748\u201355.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"1676_CR4","first-page":"636","volume":"36","author":"F Ometto","year":"2018","unstructured":"Ometto F, Fedeli U, Schievano E, Botsios C, Punzi L, Corti MC. Cause-specific mortality in a large population-based cohort of patients with rheumatoid arthritis in Italy. Clin Exp Rheumatol. 2018;36(4):636\u201342.","journal-title":"Clin Exp Rheumatol"},{"key":"1676_CR5","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036.","journal-title":"BMJ"},{"key":"1676_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-3-319-58244-3_12","volume-title":"Protein deimination in human health and disease","author":"J Fert-Bober","year":"2017","unstructured":"Fert-Bober J, Crowgey EL, Sokolove J, Giles JT, Bathon JM, Van Eyk JE. The significance of myofilament protein citrullination in heart failure: citrullination in cardiovascular diseases. In: Nicholas AP, Bhattacharya SK, Thompson PR, editors. Protein deimination in human health and disease. Cham: Springer International Publishing; 2017. p. 205\u201325."},{"issue":"1","key":"1676_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, Kvien TK, Dougados M, Radner H, Atzeni F, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76(1):17\u201328.","journal-title":"Ann Rheum Dis"},{"key":"1676_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fmed.2018.00026","volume":"5","author":"F Atzeni","year":"2018","unstructured":"Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M. Cardiovascular imaging techniques in systemic rheumatic diseases. Front Med. 2018;5:26.","journal-title":"Front Med"},{"issue":"4","key":"1676_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/acr.21861","volume":"65","author":"F Aslam","year":"2013","unstructured":"Aslam F, Bandeali SJ, Khan NA, Alam M. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res. 2013;65(4):534\u201343.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1676_CR10","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar3752","volume":"14","author":"JT Giles","year":"2012","unstructured":"Giles JT, Fert-Bober J, Park JK, Bingham CO, Andrade F, Fox-Talbot K, Pappas D, Rosen A, van Eyk J, Bathon JM, et al. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther. 2012;14(1):R39.","journal-title":"Arthritis Res Ther"},{"issue":"suppl_6","key":"1676_CR11","first-page":"vi5","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology. 2012;51(suppl_6):vi5\u20139.","journal-title":"Rheumatology"},{"issue":"6","key":"1676_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr","year":"2008","unstructured":"D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation"},{"issue":"4","key":"1676_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1756-185X.2010.01552.x","volume":"13","author":"CH Maraina","year":"2010","unstructured":"Maraina CH, Nurdayana AK, Rusni D, Azwany Y. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis. Int J Rheum Dis. 2010;13(4):335\u20139.","journal-title":"Int J Rheum Dis"},{"key":"1676_CR14","doi-asserted-by":"publisher","first-page":"198198","DOI":"10.1155\/2014\/198198","volume":"2014","author":"ML Diaz-Toscano","year":"2014","unstructured":"Diaz-Toscano ML, Olivas-Flores EM, Zavaleta-Muniz SA, Gamez-Nava JI, Cardona-Munoz EG, Ponce-Guarneros M, Castro-Contreras U, Nava A, Salazar-Paramo M, Celis A, et al. Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing. BioMed Res Int. 2014;2014:198198.","journal-title":"BioMed Res Int"},{"issue":"5","key":"1676_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3899\/jrheum.101143","volume":"38","author":"AM El-Barbary","year":"2011","unstructured":"El-Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J Rheumatol. 2011;38(5):828\u201334.","journal-title":"J Rheumatol"},{"issue":"2","key":"1676_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/cvr\/cvv185","volume":"108","author":"J Fert-Bober","year":"2015","unstructured":"Fert-Bober J, Giles JT, Holewinski RJ, Kirk JA, Uhrigshardt H, Crowgey EL, Andrade F, Bingham CO 3rd, Park JK, Halushka MK, et al. Citrullination of myofilament proteins in heart failure. Cardiovasc Res. 2015;108(2):232\u201342.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"1676_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.echo.2016.01.004","volume":"29","author":"G Cioffi","year":"2016","unstructured":"Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Mazzone C, Faganello G, Di Lenarda A, Adami S, Rossini M. Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with rheumatoid arthritis without overt cardiac disease. J Am Soc Echocardiogr. 2016;29(7):689\u201398.","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"1676_CR18","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.2310\/JIM.0b013e3182746a83","volume":"60","author":"E Vizzardi","year":"2012","unstructured":"Vizzardi E, Cavazzana I, Bazzani C, Pezzali N, Ceribelli A, Bonadei I, Franceschini F, D\u2019Aloia A, Metra M, Tincani A, et al. Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritis. J Investig Med. 2012;60(8):1204\u20138.","journal-title":"J Investig Med"},{"issue":"4","key":"1676_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/art.27349","volume":"62","author":"JT Giles","year":"2010","unstructured":"Giles JT, Malayeri AA, Fernandes V, Post W, Blumenthal RS, Bluemke D, Vogel-Claussen J, Szklo M, Petri M, Gelber AC, et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum. 2010;62(4):940\u201351.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1676_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/rheumatology\/keu368","volume":"54","author":"H Midtbo","year":"2015","unstructured":"Midtbo H, Gerdts E, Kvien TK, Olsen IC, Hirth A, Davidsen ES, Semb AG. Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology. 2015;54(3):511\u20139.","journal-title":"Rheumatology"},{"issue":"4","key":"1676_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/14397595.2014.998404","volume":"25","author":"A Sharma","year":"2015","unstructured":"Sharma A, Kaushik R, Kaushik RM, Kakkar R. Echocardiographic evaluation of diastolic dysfunction in rheumatoid arthritis - a case-control study. Mod Rheumatol. 2015;25(4):552\u20137.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1676_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/art.24148","volume":"60","author":"RL Rudominer","year":"2009","unstructured":"Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, Crow MK, Sammaritano L, Levine DM, Salmon JE. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009;60(1):22\u20139.","journal-title":"Arthritis Rheum"},{"key":"1676_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijcard.2017.03.108","volume":"240","author":"JM Davis 3rd","year":"2017","unstructured":"Davis JM 3rd, Lin G, Oh JK, Crowson CS, Achenbach SJ, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population. Int J Cardiol. 2017;240:379\u201385.","journal-title":"Int J Cardiol"},{"issue":"6","key":"1676_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/03009742.2016.1249941","volume":"46","author":"BB Logstrup","year":"2017","unstructured":"Logstrup BB, Masic D, Laurbjerg TB, Blegvad J, Herly M, Kristensen LD, Urbonaviciene G, Hedemann-Nielsen A, Ellingsen T. Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study. Scand J Rheumatol. 2017;46(6):432\u201340.","journal-title":"Scand J Rheumatol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01676-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:29:49Z","timestamp":1629934189000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01676-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1676"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01676-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study were in accordance with the 2013 Helsinki Declaration. The protocol of this study was submitted and approved by the ethics committee of Qom University of Medical Sciences with the ID of IR.MUQ.REC.1398.034. We obtained written informed consent from all of the participants prior to inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}